You are here

inversió

26.01.2022

Barcelona, January 26, 2022. Investment in health startups in the BioRegion continues to grow and again surpassed the €200 million mark for the second year in a row, despite the COVID-19 pandemic. In total, companies raised €238 million, the most to date. Venture capital funding was the main driver of this growth, with more than €187 million, or 79% of all capital, three times as much as in 2019.

83% of the venture capital raised was in operations with international investors. In fact, more than 90% of operations worth over €10 million are...

24.03.2021

This March is ending with a sudden sad farewell to Josep Baselga, a major global touchstone from the BioRegion in oncological research and the treatment of breast cancer and one of the prime driving forces behind the concept of personalized medicine.